Lobe Sciences Commences Trading Under New Name and Announces Rebranding and Corporate Update Cannabis Investing News
Algernon Pharmaceuticals Announces Receipt of Refundable Tax Credit from Australian Clinical Research Biotech Investing
Viemed Healthcare to Present at Stifel Virtual Healthcare Conference on November 18, 2020 Medical Device Investing
MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities Psychedelics Investing
Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride Medical Device Investing
Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1 Pharmaceutical Investing
Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development Medical Device Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
